Henry Pelish
Vermogen: 7 M $ op 31-05-2026
Vermogen: 7 M $ op 31-05-2026
Henry Pelish currently works at Nuvalent, Inc., as Chief Scientific Officer from 2024.
Dr. Pelish also formerly worked at Harvard University, as Research Associate.
Dr. Pelish received his doctorate degree from Harvard University, graduate degree from Stanford University, and undergraduate degree from The Johns Hopkins University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 09-04-2026 | 65.604 ( 0,1% ) | 7 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NUVALENT, INC. | Hoofd Techniek/Wetenschap/O&O | 11-07-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 4 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau